Literature DB >> 19790249

Chain reaction of amyloid fibril formation with induction of basement membrane in familial amyloidotic polyneuropathy.

Yohei Misumi1, Yukio Ando, Mitsuharu Ueda, Konen Obayashi, Hirofumi Jono, Yu Su, Taro Yamashita, Makoto Uchino.   

Abstract

Familial amyloidotic polyneuropathy (FAP) is characterized by extracellular deposition of amyloid fibrils caused by a point mutation in the transthyretin (TTR) gene. Despite data from a number of in vitro studies of TTR amyloidogenesis, many questions, including where and how these fibrils form in vivo and what is the impact of amyloid deposition on tissues, remain unanswered. Here, we analysed the relationship between amyloid fibril formation and micro-environmental changes by using autopsy cardiac tissues from 11 patients with FAP and a smooth muscle cell line. Ultrastructural studies of cardiomyocytes and vascular smooth muscle cells showed that amyloid fibrils formed first at the basement membrane and that amorphous non-fibrillar TTR deposits and premature fibrils predominated during the early stage of amyloid deposition. Immunohistochemical analyses revealed that expression of major components of the basement membrane, such as collagen IV, laminin, and fibronectin, increased in parallel with the accumulation of TTR amyloid fibrils. In vitro studies with a vascular smooth muscle cell line revealed that synthetic TTR aggregates increased expression of these basement membrane components. Serum levels of collagen IV in FAP patients were significantly higher than those in healthy controls. Our data thus indicate that TTR amyloid fibrils formed first at the basement membrane and that expression of basement membrane components that was induced by amyloid deposition contributed to further amyloid deposition. This chain reaction may have important implications for FAP pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19790249     DOI: 10.1002/path.2618

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  8 in total

1.  A cell-based high-throughput screening method to directly examine transthyretin amyloid fibril formation at neutral pH.

Authors:  Mitsuharu Ueda; Masamitsu Okada; Mineyuki Mizuguchi; Barbara Kluve-Beckerman; Kyosuke Kanenawa; Aito Isoguchi; Yohei Misumi; Masayoshi Tasaki; Akihiko Ueda; Akinori Kanai; Ryoko Sasaki; Teruaki Masuda; Yasuteru Inoue; Toshiya Nomura; Satoru Shinriki; Tsuyoshi Shuto; Hirofumi Kai; Taro Yamashita; Hirotaka Matsui; Merrill D Benson; Yukio Ando
Journal:  J Biol Chem       Date:  2019-06-05       Impact factor: 5.157

2.  Ocular Manifestations in a Chinese Pedigree of Familial Amyloidotic Polyneuropathy Carrying the Transthyretin Mutation c.401A>G (p.Tyr134Cys).

Authors:  Xiaonan Zhuang; Zhongcui Sun; Fengjuan Gao; Min Wang; Wenyi Tang; Wei Liu; Keyan Wang; Jihong Wu; Rui Jiang; Gezhi Xu
Journal:  Genes (Basel)       Date:  2022-05-16       Impact factor: 4.141

3.  Pathological changes long after liver transplantation in a familial amyloidotic polyneuropathy patient.

Authors:  Konen Obayashi; Mitsuharu Ueda; Toshinori Oshima; Satomi Kawahara; Yohei Misumi; Taro Yamashita; Hirofumi Jono; Masahide Yazaki; Fuyuki Kametani; Shu-ichi Ikeda; Yuki Ohya; Katsuhiro Asonuma; Yukihiro Inomata; Yukio Ando
Journal:  BMJ Case Rep       Date:  2012-08-18

4.  Early Generation of New PrPSc on Blood Vessels after Brain Microinjection of Scrapie in Mice.

Authors:  Bruce Chesebro; James Striebel; Alejandra Rangel; Katie Phillips; Andrew Hughson; Byron Caughey; Brent Race
Journal:  MBio       Date:  2015-09-22       Impact factor: 7.867

5.  Unusual cerebral vascular prion protein amyloid distribution in scrapie-infected transgenic mice expressing anchorless prion protein.

Authors:  Alejandra Rangel; Brent Race; Mikael Klingeborn; James Striebel; Bruce Chesebro
Journal:  Acta Neuropathol Commun       Date:  2013-06-19       Impact factor: 7.801

6.  Nd:YAG capsulotomy for the management of posterior capsular amyloidosis.

Authors:  Sasha A Mansukhani; Jose S Pulido; Sunil S Khanna
Journal:  Am J Ophthalmol Case Rep       Date:  2018-11-10

Review 7.  Molecular Mechanisms of Cardiac Amyloidosis.

Authors:  Yukihiro Saito; Kazufumi Nakamura; Hiroshi Ito
Journal:  Int J Mol Sci       Date:  2021-12-21       Impact factor: 5.923

Review 8.  Transthyretin Amyloidosis: Update on the Clinical Spectrum, Pathogenesis, and Disease-Modifying Therapies.

Authors:  Haruki Koike; Masahisa Katsuno
Journal:  Neurol Ther       Date:  2020-09-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.